Skip to main content
. 2020 Feb 18;34(3):363–379. doi: 10.1007/s40259-020-00407-0

Fig. 3.

Fig. 3

Comparison of glycan structures released from HLX02, CN-Herceptin®, and EU-Herceptin® by PNGase F. a N-glycan profiles by HILIC UPLC-FLD; the major types of glycans are labelled beside the corresponding peaks in the top panel (HLX02). bf Quantitative results of each glycoform subtype analyzed using tier 2 attribute criteria (mean ± 3 SD). CN China-sourced, EU Europe-sourced, HILIC UPLC-FLD hydrophilic interaction–ultra performance liquid chromatography–fluorescence detection, SD standard deviation